Silexan in anxiety disorders: Clinical data and pharmacological background

Volume: 19, Issue: 6, Pages: 412 - 420
Published: Jun 19, 2017
Abstract
Objectives: Silexan is a lavender oil preparation available in 80-mg capsules. Here we review clinical trials investigating its anxiolytic efficacy, safety and tolerability in humans, as well as preclinical investigations supporting this therapeutic use.Methods: Besides three selected publications reporting preclinical investigations, seven clinical trials are included, of which five had a treatment duration of 6 or 10 weeks. Primary outcome...
Paper Details
Title
Silexan in anxiety disorders: Clinical data and pharmacological background
Published Date
Jun 19, 2017
Volume
19
Issue
6
Pages
412 - 420
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.